Unternehmen
ASPHALION SL
ASPHALION SL – Unternehmen mit Aktivitäten in Forschung und Innovation.
Forschungsprojekte
- Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle. ETERNAL aims to contribute to sustainable development of pharmaceutical manufacture, use and disposal, by usi…
- A game changer for the treatment of osteoarthritis: a cost effective combined advanced therapy to treat knee osteoarthritis According to the WHO Osteoarthritis (OA) is one major course of years lived with disability in the elderly an…
- RBD Dimer recombinant protein vaccine against SARSCoV2 The main objective of RBDCOV project is to test the efficacy, tolerability, and safety of a new vaccine again…
- Development and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survival "Fever is the leading reason to seek healthcare globally, with over 1 billion cases of febrile illness occurr…
- smart and multiFunctional 3D printable prO-Regenerative biologiCal matrix modulating mEchanotRansduction as advancEd theraPy to treAt skIn chRonic wounds Due to population lifestyle changes, i.e. obesity, diabetes and aging population, chronic wounds (CW) which f…
- DNA methylation markers to predict treatment success of biologicals in Crohn’s disease. Monoclonal antibodies have become a mainstay of therapy in common immune-mediated diseases (IMID) including C…
- ANTIMICROBIAL NANOSTRUCTURED BIOMATERIALS FOR COMPLEX WOUND HEALING Complex wounds are a global health problem with significant impact on the health care economy. In developed c…
- Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors "The PragmaTIL trial aims to optimize treatment of cancer patients with Tumour-Infiltrating Lymphocytes Adopt…
- ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES Autoimmune diseases are currently treated with immunosuppressive and supportive therapies, which dampen infla…